Shares of Enzo Biochem Inc. (NYSE:ENZ) shot up 3.9% during mid-day trading on Monday . The stock traded as high as $6.18 and last traded at $6.17, with a volume of 185,746 shares trading hands. The stock had previously closed at $5.94.

Separately, Zacks Investment Research cut shares of Enzo Biochem from a “hold” rating to a “sell” rating in a research report on Tuesday, March 15th.

The firm has a 50 day moving average price of $5.97 and a 200 day moving average price of $5.04. The firm has a market capitalization of $285.91 million and a PE ratio of 16.18.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings data on Wednesday, June 8th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $18.16 million for the quarter, compared to the consensus estimate of $24.50 million. During the same period in the previous year, the business posted ($0.07) earnings per share. Equities analysts anticipate that Enzo Biochem Inc. will post ($0.23) earnings per share for the current year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.